## 

|Trustees'<br>Report|Trustees'<br>Report||||
|---|---|---|---|---|
|Statement of|Trustees'|Responsibilities||17|
|Independent|Auditor's|Report to the Members of Martin|House|18|
|Consolidated|Statement|of Financial Activities||22|
|Balance Sheets||||23|
|Consolidated|Cash Flow Statement|||24|
|Notes to the|Financial Statements|||25|





## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 



## 



## 

## 



|Trustees||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Name||Declaration(s)||||||||||||||||
|Zoe Donaldson||Deputy|Director for NHS England.|||||||||||||||
|||Husband|is a GP in|the|locality.|||||||||||||
|Tim Halstead||Director|and Chief|Operating||Officer||||of Switalskis|||Solicitors||Limited|||
|||Director|of Martin|House (Shops)||||Ltd||||||||||
|Rifhat Malik MBE||Director|Of Give a Gift charity|||||||||||||||
|||Executive<br>Board Member<br>of||||LCP|||HATCH|||covering||East and||North|East|
|||Leeds.||||||||||||||||
|Patricia McKinney||Nil||||||||||||||||
|Mike Millington||Nil||||||||||||||||
|Stephen<br>Plews||Nil||||||||||||||||
|Gordon Singer||Nil||||||||||||||||
|Jenny Slee||Nil||||||||||||||||
|Tim Straughan||Director|of NHS England|||||||||||||||
|||Non-Executive<br>Director|||ofSpectrum|||||CIC||||||||
|||Director|ofCitizone|Ltd||||||||||||||
|||Director|of Martin|House Shops (Ltd)||||||||||||||
|Jenny Wilkinson||Director|ofWessex|Court Flats|||Scarborough|||||Ltd||||||
|||Director|of Martin|House Shops Ltd||||||||||||||
|Jayne Price||Professor<br>in Children's|||Nursing||Kingston||||University.|||||||
|||Chair of Research||Governance||||Committee||||at Shooting|||Star|Children' s||
|||Hospices.||||||||||||||||
|Shiela Puri||I-lusband|is a Consultant||Urologist||||at|the|Yorkshire|||Clinic, Bradford||||
|Senior Staff||||||||||||||||||
|Name||Declaration(s)||||||||||||||||
|Clair Holdsworth||Nil||||||||||||||||
|Rebecca Wynne||Nil||||||||||||||||
|Victoria Greensmith||Nil||||||||||||||||
|Antoinette<br>Stewart||Nil||||||||||||||||
|Lindsey Fellowes-Freeman<br>Nil||||||||||||||||||
|Our Trustees||||||||||||||||||
|The Trustees,|who|are also Directors, are the||members|||of|the||charitable|||company,||the equity<br>being|||
|limited<br>by guarantee||and therefore|having<br>no|share capital.|||||As at||30|April|2023, Martin|||House|has 12|
|Trustees.||||||||||||||||||





|oe Donaldson||||Member ofthe Clinical Effectiveness|Committee|Committee||||
|---|---|---|---|---|---|---|---|---|---|
|imothy<br>J Halstead||LLB||Chair ofthe Board ofTrustees||||||
|||||Member ofthe Finance and Resources Committee||||||
|Rifhat Malik MBE||||Member ofthe Clinical Effectiveness||Committee||||
|Professor Patricia||McKinney||Member ofthe Clinical Effectiveness||Committee||||
|Michael Millington||BScHons MBA||Member ofthe Finance and Resources Committee||||||
|tephen<br>A Plews||||Member ofthe Finance and Resources Committee||||||
|Gordon Singer||||Member ofthe Finance and Resources Committee||||||
|enny Slee (Cromack)|||LLB|Member ofthe Clinical Effectiveness||Committee||||
|im Straughan||||Chair ofthe Finance and Resources|Committee|||||
|ennifer Wilkinson||||Member ofthe Clinical Effectiveness||Committee||||
|Professor Jayne|Price|||ppointed<br>13October 2022||||||
|||||ice Chair ofthe Clinical Effectiveness||Committee||||
|Dr Shiela Puri||||ppointed<br>13October 2022||||||
|||||ppointed<br>Chair ofthe Clinical Effectiveness<br>Committee||||on 2||
|||||p ril 2023||||||
|Professor John|Barry||Wright|Chair ofthe Clinical Effectiveness<br>Committee<br>(resigned||||21|Jul|
|||||2022)||||||
|Dr Anne-Marie|Childs|||Member ofthe Clinical Effectiveness||Committee|(resigned||16|
|||||February 2023)||||||
|ue Rumbold||||ice Chair ofthe Board ofTrustees||||||
|||||Member ofthe Clinical Effectiveness||Committee|(resigned||27|
|||||pril 2023)||||||



## 



## 

## 



## 

## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

|||||Note|2023|2023|2023|2023|2022|
|---|---|---|---|---|---|---|---|---|---|
||||||Unrestricted<br>Funds—|Unrestricted<br>Funds-|Restricted<br>Funds|Total<br>Funds|Total<br>Funds|
||||||General|Designated|E|E|E|
||||||E|E||||
|Income from:||||||||||
|Donations|||||1,988,362||1,674,406|3,662,768|2,092,889|
|Legacies|||||1,162,306|||1,162,306|1,240,716|
|Income/rom<br>charitable<br>activities:||||||||||
|Funding<br>from Integrated|Care||Boards||||890,291|890,291|870,301|
|NHS England grants|||||||984,229|984,229|828,549|
|Covid 19grants||||||18,110|6,942|25,052|157,045|
|Other income|||||40,325|||40,325|76,870|
|Other tradina activities:||||||||||
|Income from retail operations|||||1,870,419|||1,870,419|1,672,940|
|Fundraising<br>events and lottery|||||1,175,227|||1,175,227|812,793|
|Other activities for generating|||funds||47,482|||47,482|29,705|
|Income from investments|||||403,284|||403,284|372,342|
|Total income|||||6,687,405|18,110|3,555,868|10,261,383|8,154,150|
|Expenditure<br>on:||||||||||
|Expenditure<br>on roising funds:||||||||||
|Cost ofgenerating<br>voluntary||income|||1,492,702||1,279|1,493,981|1,425,856|
|Cost of retail operations|||||1,391,321|18,110||1,409,431|1,232,704|
|Cost offundraising<br>events, <br>and other activities||lottery|||682,484|||682,484|583,213|
|Investment<br>managers<br>cost|||||52,269|||52,269|70,474|
|Expenditure<br>on charitable||activities|||4,090,564||2,189,990|6,280,554|5,777,256|
|Total expenditure|||||7,709,340|18,110|2,191,269|9,918,719|9,089,503|
|Net (expenditure)/income||before||||||||
|net (losses)/gains<br>on investments|||||(1,021,935)||1,364,600|342,665|(935,353)|
|Net losses on investments||||||(648,954)||(648,954)|(661,498)|
|Net (expenditure)/income||before transfers|||(1,021,935)|(648,954)|1,364,600|(306,289)|(1,596,851)|
|Transfers between<br>funds||||17|2,317,631|(2,315,370)|(2,261)|||
|Net movement<br>in funds for the year|||||1,295,696|(2,964,324)|1,362,339|(306,289)|(1,596,851)|
|Funds brought<br>forward at beginning<br>ofyear|||||4,821,272|18,511,733|79,454|23,412,459|25,009,310|
|Funds carried forward at|end||of|17,18|6,116,968|15,547,409|1,441,793|23,106,170|23,412,459|
|year||||||||||





||||||||Group||Charity|Charity|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||2023|2022|2023|2022|
||||||||||E|E|
|Fixed assets|||||||||||
|Tangible assets||||||9|4,583,898|4,176,808|4,583,898|4,176,808|
|Investments||||||20|16,885,021|18,510,385|16,885p023|18,510,387|
||||||||21,468,919|22,687,193|21,468,921|22,687,195|
|Current assets|||||||||||
|Stock||||||11|22,310|28,194|20,880|24,066|
|Debtors||||||22|1,938,509|1,183,721|1,944,458|1,194,659|
|Cash on deposit, at|||bank and|in hand||23|1,061,751|907,297|1,050,921|896,123|
||||||||3,022,570|2,119,212|3,016,260|2,114,848|
|Creditors: amounts|||falling due within||one year||(1,385,319)|(1,393,946)|(1,381,569)|(1,391,546)|
|Net current assets|||||||1,637,251|725,266|1,634,691|723,302|
|Net assets|||||||23,106,170|23,412,459|23,103,611|23,410,497|
|Funds ofthe|charity:||||||||||
|Restricted funds||||||17|1,441,793|79,454|1,441,793|79,454|
|Unrestricted|funds||are represented||by:||||||
|Deficit budget|fund|||||27|2,000,000|4,300,000|2,000,000|4,300,000|
|Refurbishment|fund|||||27|10,500,000|10,500,000|10,500,000|10,500,000|
|Other investment||funds||||17|3,047,409|3,711,733|3,047,411|3,711,735|
|Total unrestricted||designated||funds|||1S,547,409|18,511,733|15,547,411|18,511,735|
|Unrestricted|tangible fixed assets|||||18|4,583,898|4,176,808|4,583,898|4,176,808|
|Undesignated|general funds|||||28|1,533,070|644,464|1,530,509|642,500|
|Total unrestricted||funds|||||21,664,377|23,333,005|21,661,818|23,331,043|
||||||||23,106,170|23,412,459|23,103,611|23,410,497|





## 

|||||||2023||2022||
|---|---|---|---|---|---|---|---|---|---|
|||||||E|E|E||
|Cash flows from operating<br>activities:||||||||||
|Net cash used in operating<br>activities|||||||(427,264)||(719,290)|
|Cash flows from investing<br>activities:||||||||||
|Dividends,<br>interest<br>and rents from investments|||||354,526|||336,063||
|Purchase oftangible<br>fixed assets|||||(756,386)|||(641,885)||
|Proceeds from the sale oftangible fixed assets||||||7,168||32,774||
|Payments to acquire investments|||||(395,786)|||(2,823,233)||
|Proceeds from the sale of investments|||||1,254,335|||3,134,813||
|Net cash provided<br>by investing|activities||||||463,857||38,532|
|Change<br>in cash and cash equivalents|||in the|year|||36,593||(680,758)|
|Cash and cash equivalents<br>at the beginning||||ofthe|||1,285,132||1,965,890|
|year||||||||||
|Cash and cash equivalents<br>at the end|||ofthe|year|||1,321,725||1,285,132|
|Reconciliation<br>ofnet income to|net|cash flow from|||operating|activities||||
|||||||||2023|2022|
|||||||||E|E|
|Net expenditure<br>for the year||||||||(306,289)|(1,596,851)|
|Depreciation<br>charge||||||||347,189|329,522|
|Loss on investments||||||||648,954|661,498|
|Dividends,<br>interest and rents from||investments||||||(403,284)|(372,342)|
|Profit on sale of fixed assets||||||||(5,061)|(25,343)|
|Decrease/(increase)<br>in stock||||||||5,884|(23,593)|
|(increase)/decrease<br>in debtors||||||||(706,030)|491,117|
|Decrease in creditors||||||||(8,627)|(183,298)|
|Net cash (outflow) from operating||activities||||||(427,264)|(719,290)|
|Analysis of changes<br>in net funds||||||||||
|||||||At|30 April|Cash flow|At 30 April|
||||||||2022||2023|
||||||||E||E|
|Cash at bank and in hand|||||||907,297|154,454|1,061,751|
|Cash equivalents|||||||377,835|(117,861)|259,974|
|||||||1,285,132||36,593|1,321,725|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|2<br>Net expenditure|2<br>Net expenditure||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2023|2022|
||||||||||E|E|
|Net expenditure|isstated after charging/(crediting):||||||||||
|Depreciation<br>of|tangible||fixed|assets|||||347,189|329,522|
|Loss/(profit)<br>on|disposal||offixed assets||||||(5,061)|(25,343)|
|Auditor's<br>remuneration|||—audit of charity|||and subsidiary|company|accounts|15,675|12,900|
|Auditor's<br>remuneration|||—other non-audit|||services|||2,300|2,100|
|Operating<br>lease|rentals||—land|and buildings|||||199,779|202,695|
|Operating<br>lease|rentals||—equipment||||||3,959|25,379|
|3<br>Income from investments|||||||||||
||||||||||2023|2022|
||||||||||E|E|
|Gross dividends|and interest|||receivable|from listed investments||||396,047|363,181|
|Interest from building||society||and banks|||||1,812|186|
|Property rent|||||||||3,625|8,975|
|Lease incentive|gipon|Shop|||||||1,800||
||||||||||403,284|372,342|



## 

|Martin<br>House under|Gift Aid.|||
|---|---|---|---|
|||2023|2022|
|||E|E|
|Profit and loss account||||
|Turnover||70,972|75,971|
|Cost of sales||(28,235)|(30,486)|
|Gross profit||42,737|45,485|
|Rent and rates||(6,381)|(6,149)|
|Staff costs||(22,711)|(25,607)|
|Other expenses||(9,949)|(10,958)|
|Interest payable to|parent company|(1,137)|(809)|
|Profit for the year||2,559|1,962|
|Balance Sheet||||
|Share capital||2|2|
|Profit and loss account||2,559|1,962|
|Total shareholder's|funds|2,561|1,964|





## 

|||||Unrestricted|Restricted|Tota I|
|---|---|---|---|---|---|---|
|For the year ended|30April 2023|||2023<br>f|2023<br>E|2023<br>f|
|Costs ofgenerating|donations||&legacies||||
|Staff costs (Note 8)||||1,137,983||1,137,983|
|Publicity and newsletters||||205,138||205,138|
|Professionalfees||||12,508||12,508|
|Other||||137,073|1,279|138,352|
|||||1,492,702|1,279|1,493,981|
|Cost of retail operations|||||||
|Staff costs (Note 8)||||798,615||798,615|
|Other||||610,816||610,816|
|||||1,409,431||1,409,431|
|Lottery and event costs|||||||
|Staff costs (Note 8)||||145,599||145,599|
|Other||||536,885||536,885|
|||||682,484||682,484|
|Investment<br>management||costs||52,269||52,269|
|||||Unrestricted|Restricted|Total|
|For the year ended|30April 2022|||2022<br>f|2022<br>f|2022<br>f|
|Costs ofgenerating|donations||&legacies||||
|Staff costs (Note 8)||||924,986||924,986|
|Publicity<br>and newsletters||||286,330||286,330|
|Professional<br>fees||||17,869||17,869|
|Other||||196,671||196,671|
|||||1,425,856||1,425,856|
|Cost of retail operations|||||||
|Staff costs (Note 8)||||610,337||610,337|
|Other||||622,367||622,367|
|||||1,232,704||1,232,704|
|Lottery and event costs|||||||
|Staff costs (Note 8)||||132,393||132,393|
|Other||||450,820||450,820|
|||||583,213||583,213|
|Investment<br>management||costs||70,474||70,474|





## 

## 

||Unrestricted|Restricted|Tote I|Unrestncted|Restricted|Total|
|---|---|---|---|---|---|---|
||2023|2023|2023|2022|2022|2022|
||E|E|E|E|E|E|
|Provision ofcare:|||||||
|Staff costs (Note 8)|1,935,933|2,181,612|4,117,545|1,821,632|1,885,392|3,707,024|
|Consumables|210,036||210,036|186,772||186,772|
|Other|450,800|8,378|459,178|416,788|18,541|435,329|
|Research|(30,000)||(30,000)|111,836||111,836|
|Support costs:|||||||
|Staff costs (Note 8)|1,144,142||1,144,142|767,238|22,426|789,664|
|Establishment|379,653||379,653|546,070|561|546,631|
||4,090,564|2,189,990|6,280,554|3,850,336|1,926,920|5,777,256|



## 

|Year ended 30 April|2023|Staff costs|Depreciation|Other costs|Tote I|
|---|---|---|---|---|---|
|||E|E|E|E|
|Charitable<br>activities||5,261,687|257,373|761,494|6,280,554|
|Costs ofgenerating|funds|2,082,197|89,816|1,466,152|3,638,165|
|Total expenditure||7,343,884|347,189|2,227,646|9,918,719|
|Year ended 30 April|2022|Staff costs|Depreciation|Other costs|Tota I|
|||E|E|E|E|
|Charitable<br>activities||4,496,688|245,435|1,035,133|5,777,256|
|Costs of generating|funds|1,667,716|84,087|1,560,444|3,312,247|
|Total expenditure||6,164,404|329,522|2,595,577|9,089,503|



## 

|||Average headcount||Average|FTE|
|---|---|---|---|---|---|
|||2023|2022|2023|2022|
|||No.|No.|No.|No.|
|Charitable|activities —care team and support|134|129|115|108|
|Fundraising|and shops|66|62|58|54|
|||200|191|173|162|
|The aggregate|payroll costs ofthese persons were as follows:|||||
|||||2023|2022|
|||||E|E|
|Wages and salaries||||6,271,922|5,327,572|
|Social security|costs|||595,762|461,438|
|Other pension|costs (Note 15)|||476,200|375,394|
|||||7,343,884|6,164,404|





## 

## 

## 

|9.<br>Tangible fixed assets|||||||
|---|---|---|---|---|---|---|
|||||Office|||
||||Furniture|furniture|||
||Freehold<br>land|Assets under|and|and||Total|
|CHARITY AND GROUP|and buildings|construction|fittings|equipment|Vehicles||
||f|E|E|f|f||
|Cost|||||||
|At beginning<br>ofyear|4,805,271|820,714|1,670,027|1,145,463|195,262|8,636,737|
|Additions|12,355|418,482|157,671|108,428|59,452|756,388|
|Disposals|||||(16,771)|(16,771)|
|At end ofyear|4,817,626|1,239,196|1,827,698|1,253,891|237,943|9,376,354|
|Depreciation|||||||
|At beginning<br>ofyear|2,014,817||1,483,474|862,816|98,822|4,459,929|
|Charge for year|94,882||110,001|112,228|30,078|347,189|
|On disposals|||||(14,662)|(14,662)|
|At end ofyear|2,109,699||1,593,475|975,044|114,238|4,792,456|
|Net book value|||||||
|At 30April 2023|2,707,927|1,239,196|234,223|278,847|123,705|4,583,898|
|At 30April 2022|2,790,454|820,714|186,553|282,647|96,440|4,176,808|



|CHARITY|||||2023|2022|
|---|---|---|---|---|---|---|
||||||f|E|
|Listed investments||(Note 10(a))|||16,475,037|17,982,540|
|Cash held|as part of||investment|portfolio|259,974|377,835|
|Investment|in Martin||I-louse (Shops) Limited (Note 4)||2|2|
|Unlisted<br>investment|||||10|10|
|Investment|property||(Note 10(b))||150,000|150,000|
||||||16,885,023|18,510,387|





## 

|GROUP|||||2023|2022|
|---|---|---|---|---|---|---|
||||||E|E|
|Listed investments||(Note 10(a))|||16,475,037|17,982,540|
|Cash held|as part of||investment|portfolio|259,974|377,835|
|Unlisted<br>investment|||||10|10|
|Investment|property||(Note 10(b))||150,000|150,000|
||||||16,885,021|18,510,385|



||||||2023|2022|
|---|---|---|---|---|---|---|
||||||E|E|
|Market value at beginning|||of year||17,982,540|18,955,618|
|Additions|||||395,786|2,823,233|
|Disposal|proceeds||||(1,254,335)|(3,134,813)|
|Realised|and unrealised<br>investment|||gains|(648,954)|(661,498)|
|Market value at end ofyear|||||16,475,037|17,982,540|
|Historical|cost at|end of year|||13,726,157|14,033,725|
|10(b) Investment||property|||||
||||||2023|2022|
||||||E|E|
|Market value at b||eginning|and end|ofyear|150,000|150,000|



|10(b) Investment|property|||
|---|---|---|---|
|Market value at|beginning|and end|ofyear|



## 

||||Group||Charity||
|---|---|---|---|---|---|---|
||||2023|2022|2023|2022|
||||E|E|E|E|
|Goods|for resale||2,064|5,948|634|1,820|
|T-shirt|stock fundraising|(not for resale)|20,246|22,246|20,246|22,246|
||||22,310|28,194|20,880|24,066|





## 

|12|Debtors|Debtors||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||Group||Charity||
|||||||Due within|Due within|Due within|Due within|
|||||||one year|one year|one year|one year|
|||||||2023|2022|2023|2022|
|||||||E|E|f|f|
|Amounts||due from Martin|||House (shops) Limited|||5,949|10,938|
|Accrued||income and prepayments||||1,834,412|1,104,717|1,834,412|1,104,717|
|VAT|recoverable|||||104,097|79,004|104,097|79,004|
|||||||1,938,509|1,183,721|1,944,458|1,194,659|
|13|Cash at bank,||in hand||and on deposit|||||
|||||||Group||Charity||
|||||||2023|2022|2023|2022|
|||||||f|E|E|E|
|Bank and building|||society||deposits|1,060,634|905,155|1,050,634|895,154|
|Cash|in hand|||||1117|2,142|287|969|
|||||||1,061,751|907,297|1,050,921|896,123|
|14|Creditors: amounts|||falling due within one year||||||
|||||||Group||Charity||
|||||||2023|2022|2023|2022|
|||||||f|E|f|E|
|Trade creditors||||||183,207|264,887|183,207|264,887|
|Other taxes and social||||security costs||144,755|127,491|144,755|127,491|
|Other creditors||||||24,017|156,255|24,017|156,255|
|Accruals||and deferred||income||1,033,340|845,313|1,029,590|842,913|
|||||||1,385,319|1,393,946|1,381,569|1,391,546|





## 

## 

|treated as defined<br>co|ntribution<br>schemes as disclosed<br>in Not|e 1.||
|---|---|---|---|
|||2023|2022|
|||E|E|
|Nl-IS Pension Scheme||246,808|234,743|
|Defined contribution|scheme|229,392|140,651|
|||476,200|375,394|



## 

## 

## 

||||Land and||Land and||
|---|---|---|---|---|---|---|
||||buildings|Equipment|buildings|Equipment|
||||2023|2023|2022|2022|
||||E|E|E|E|
|Within|one|year|153,054|3,959|162,815|9,443|
|More|than|one year and less than 5years|367,972||317,963|3,959|
|More|than|5 years|50,500||88,063||
||||571,526|3,959|568,841|13,402|





## 

|17<br>Statement offunds|17<br>Statement offunds|||||||
|---|---|---|---|---|---|---|---|
|For the year ended <br>2023|30April|As At<br>1May<br>2022|Income|Expenditure|Investment<br>(losses)|Transfers|As at<br>30April<br>2023|
|GROUP||||||E|E|
|Unrestricted<br>funds||||||||
|General funds||4,821,272|6,687,405|(7,709,340)||2,317,631|6,116,968|
|Designated<br>funds||||||||
|Covid-19 fund|||18,110|(18,110)||||
|Deficit budget fund||4,300,000||||(2,300,000)|2,000,000|
|Refurbishment<br>fund||10,500,000|||||10,500,000|
|Other investment<br>funds||3,711,733|||(648,954)|(15,370)|3,047,409|
|Total designated<br>funds||18,511,733|18,110|(18,110)|(648,954)|(2,315,370)|15,547,409|
|Total unrestricted|funds|23,333,005|6,705,512|(7,727,450)|(648,954)|2,261|21,664,377|
|CHARITY||||||||
|Unrestricted<br>funds||||||||
|General funds||4,819,308|6,687,403|(7,709,935)||2,317,631|6,114,407|
|Designated<br>funds||||||||
|Covid-19 fund|||18,110|(18,110)||||
|Deficit budget fund||4,300,000||||(2,300,000)|2,000,000|
|Refurbishment<br>fund||10,500,000|||||10,500,000|
|Other investment<br>funds||3,711,735|||(648,954)|(15,370)|3,047,411|
|Total designated<br>funds||18,511,735|18,110|(18,110)|(648,954)|(2,315,370)|15,547,411|
|Total unrestricted|funds|23,331,043|6,705,511|(7,728,045)|(648,954)|2,261|21,661,818|
|GROUP AND CHARITY||||||||
|Restricted<br>Funds||||||||
|NHS England<br>grant|||917,229|(917,229)||||
|Pension<br>indexation|funding||67,000|(67,000)||||
|Integrated<br>Care Board Grants|||890,291|(890,291)||||
|Hospice<br>UK|||6,942|(6,942)||||
|Garden<br>Fund||11,344|||||11,344|
|Rebuild||28,975|||||28,975|
|Care equipment<br>- Regional||4,989||(164)||(636)|4,189|
|Donations<br>- Care equipment||612|||||612|
|Donations<br>—Capital (baths,<br>decoration,<br>chair, training)<br>Donations<br>-Trusts<br>Donations —Capital Appeal<br>Donations —Events||33,534|602,421<br>1,070,396<br>1,589|(33,500)<br>(274,553)<br>(1,589)||(1,625)|34<br>326,243<br>1,070,396|
|||79,454|3,555,868|(2,191,268)||(2,261)|1,441,793|





## 

|Notes to the Financial Sta|tements<br>|(continued)|||||
|---|---|---|---|---|---|---|
|17 Statement<br>offunds (Conrinuedi|||||||
|For the year ended 30 April<br>2022|As At<br>1May<br>2021|Income|Expenditure|Investment<br>gains|Transfers|As at<br>30 April<br>2022|
|GROUP|||||||
|Unrestricted<br>funds|||||||
|General funds|5,665,680|6,186,920|(7,142,278)||110,950|4,821,272|
|Designated<br>funds|||||||
|Covid-19 fund||20,305|(20,305)||||
|Deficit budget<br>fund|4,346,846||||(46,846)|4,300,000|
|Refurbishment<br>fund|10,451,806||||48,194|10,500,000|
|Other investment<br>funds|4,374,450|||(661,498)|(1,219)|3,711,733|
|Total designated<br>funds|19,173,102|20,305|(20,305)|(661,498)|129|18,511,733|
|Total unrestricted<br>funds|24,838,782|6,208,225|(7,163,583)|(661,498)|111,079|23,333,005|
|CHARITY|||||||
|Unrestricted<br>funds|||||||
|General funds|5,470,609|6,307,828|(7,070,079)||110,950|4,819,308|
|Designated<br>funds|||||||
|Covid-19 fund||20,305|(20,305)||||
|Deficit budget<br>fund|4,346,846||||(46,846)|4,300,000|
|Refurbishment<br>fund|10,451,806||||48,194|10,500,000|
|Other investment<br>funds|4,374,452|||(661,498)|(1,219)|3,711,735|
|Total designated<br>funds|19,173,104|20,305|(20,305)|(661,498)|129|18,511,735|
|Total unrestricted<br>funds|24,643,713|6,328,133|(7,090,384)|(661,498)|111,079|23,331,043|
|GROUP AND CHARITY|||||||
|Restricted<br>Funds|||||||
|Nl-IS England<br>grant||763,549|(763,549)||||
|Pension<br>indexation<br>funding||65,000|(65,000)||||
|Clinical Commissioning<br>Groups'<br>grants||870,301|(870,301)||||
|Hospice<br>UK||136,740|(136,740)||||
|Whitby<br>Lodge Courtyard<br>project|16,500||(4,500)||(656)|11,344|
|Wet wheels trips/<br>Art Fund|28,975|||||28,975|
|Music and animation<br>suite|12,200||(12,200)||||
|Other capital funds|25||(25)||||
|Care equipment<br>(regional|12,853||(3,604)||(9,249)||
|team for care)|||||||
|Other restricted<br>donations|4,989|||||4,989|
|Trust donations<br>for|1,142|1,000|(2,142)||||
|project/designated<br>spend|||||||
|Network<br>co-ordinator|2,404||(2,404)||||
|Children's<br>Palliative<br>Care|32,268|17,024|(17,024)||(32,268)||
|Network|||||||
|CNS S,bereavement<br>funding|12,608||(5,965)||(6,643)||
|Primary care for young<br>people|11,400||(5,800)||(5,600)||
|Donations<br>care equipment|6,112|4,906|(1,000)||(9,406)|612|
|Donations<br>capital (baths,<br>decoration,<br>chair, training)|29,052|88,405|(36,666)||(47,257)|33,534|
||170,528|1,946,925|(1,926,920)||(111,079)|79,454|





## 



## 

## 

|As at 30 April|As at 30 April|2023||Tangible|Investments|Net current|Tota I|
|---|---|---|---|---|---|---|---|
|||||fixed assets||assets||
|GROUP||||6||E||
|Restricted|funds|||||1,441,793|1,441,793|
|Unrestricted||funds|- Designated||15,547,409||15,547,409|
||||- Other|4,583,898|1,337,612|195,458|6,116,968|
|||||4,583,898|16,885,021|1,637,251|23,106,170|
|CHARITY||||||||
|Restricted|funds|||||1,441,793|1,441,793|
|Unrestricted||funds|- Designated||15,547,411||15,547,411|
||||- Other|4,583,898|1,337,612|192,897|6,114,407|
|||||4,583,898|16,885,023|1,634,690|23,103,611|
|As at 30April||2022||Tangible|Investments|Net current|Tota I|
|||||fixed assets||assets||
|GROUP||||E||E||
|Restricted|funds|||||79,454|79,454|
|Unrestricted||funds|- Designated||18,511,733||18,511,733|
||||- Other|4,176,808|(1,348)|645,812|4,821,272|
|||||4,176,808|18,510,385|725,266|23,412,459|
|CHARITY||||||||
|Restncted|funds|||||79,454|79,454|
|Unrestricted||funds|- Designated||18,511,735||18,511,735|
||||- Other|4,176,808|(1,348)|643,848|4,819,308|
|||||4,176,808|18,510,387|723,302|23,410,497|





## 

## 



## 

||||||2022|2022|2022|2022|
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted<br>Funds—|Unrestricted<br>Funds-|Restricted<br>Funds|Total<br>Funds|
||||||General|Designated|E|E|
||||||E|E|||
|Income from:|||||||||
|Donations|||||1,998,578||94,311|2,092,889|
|Legaaes|||||1,240,716|||1,240,716|
|fncome from charitable<br>octivitiesi|||||||||
||||||||870,301|870,301|
|NH5 England grants|||||||828,549|828,549|
|Covid 19grants||||||20,305|136,740|157,045|
|Other income|||||59,846||17,024|76,870|
|Other trading activities:|||||||||
|Income from retail|operations||||1,672,940|||1,672,940|
|Fundra ising events|and lottery||||812,793|||812,793|
|Other activities for|generating||funds||29,705|||29,705|
|Income from investments|||||372,342|||372,342|
|Total income|||||6,186,920|20,305|1,946,925|8,154,150|
|Expenditure<br>on:|||||||||
|Expenditure<br>on raising/ands:|||||||||
|Cost ofgeneratmg|voluntary|income|||1,425,856|||1,425,856|
|Cost of retail operations|||||1,214,442|18,262||1,232,704|
|Cost offundraismg<br>other activities|events,|lottery and|||583,213|||583,213|
|Investment<br>managers<br>cost|||||70,474|||70,474|
|Expenditure<br>on charitable||activities|||3,848,293|2,043|1,926,920|5,777,256|
|Totalexpenditure|||||7,142,278|20,305|1,926,920|9,089,503|
|Net income/(expenditure)||before net|||||||
|(losses)/gains<br>on investments|||||(955,358)||20,005|(935,353)|
|Net gains/(losses)|on investments|||||(661,498)||(661,498)|
||||||(955.358)|(661,498)|20,005|(1,596,851)|
|Transfers between|funds||||110,950|129|(111,079)||
|Net movement<br>in|funds for the year||||(844,408)|(661,369)|(91,074)|(1,596,851)|
|Funds brought<br>forward at beginning||||of|5,665,680|19,173,102|170,528|25,009,310|
|year|||||||||
|Funds carried forward at end|||ofyear||4,821,272|18,511,733|79,454|23,412,459|